Financial Year |
March 31 2023 |
Monetary Funds |
10,022,951,540.90 |
Held-for-trading Financial Assets |
10,007,313,817.30 |
Notes Receivable |
-- |
Accounts Receivable |
3,164,884,193.28 |
Advances to Suppliers |
1,605,252,429.97 |
Other Receivables |
318,677,825.68 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
16,552,623.93 |
Dividend Receivable |
-- |
Inventories |
1,584,490,602.38 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
589,679,383.16 |
Total Current Assets |
27,391,020,098.99 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
18,724,049,714.03 |
Investment Properties |
-- |
Fixed Assetes |
29,708,264,758.03 |
Under-construction Projects |
5,521,398,808.91 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
1,340,677,956.02 |
R&D expenses |
-- |
Goodwill |
12,566,464.43 |
Long-Term Deferred and Prepaid Expenses |
18,799,515.99 |
Deferred Income Tax Assets |
950,259,335.28 |
Other Non-Current Assets |
155,509,091.56 |
Sub-Total of Non-Current Assets |
57,842,393,873.09 |
Total Assets |
85,233,413,972.08 |
Short-Term Loans |
8,806,332,157.32 |
Trading Financial liabilities |
-- |
Notes Payable |
3,385,649,104.07 |
Accounts Payable |
2,396,618,299.92 |
Accounts Received In Advance |
808,188.41 |
Employee Compensation Payable |
285,148,522.53 |
Taxes Payable |
274,596,340.70 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
1,822,511,868.13 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
1,935,274,945.30 |
Other Current Liabilities |
86,900,958.83 |
Sub-Total of Current Liabilities |
20,842,770,950.37 |
Long-term Loans |
24,820,790,097.30 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
335,435,212.27 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
25,445,749,079.48 |
Total Liabilities |
46,288,520,029.85 |
Paid-In Capital(Or Share Stock) |
3,778,079,704.00 |
Capital Surplus |
17,223,019,516.79 |
Surplus Reserve |
3,378,908,998.65 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
2,929,597,218.30 |
Minority Stockholder's Interest |
10,004,981,173.71 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
28,939,912,768.52 |
Owner's Equity(Stockholder's Equity) |
38,944,893,942.23 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
85,233,413,972.08 |